Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
European Journal of Neurology
|
November 17, 2025
Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe
Veronica Sian, Maria Francesca Di Feo, Sergei Kurbatov, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
April 27, 2020
Disability and quality of life in Guillain-Barré syndrome - Longitudinal study
Ivana Berisavac, Mirjana Arsenijevic, Ivo Bozovic, et al.
Journal of Neurology
|
November 1, 2017
Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Ivo Bozovic, Aleksandra Kacar, Stojan Peric, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 2, 2020
Incidence and mortality rates of Guillain-Barré syndrome in Serbia
Aleksandar Stojanov, Ivana Berisavac, Ivo Bozovic, et al.
The Lancet. Neurology
|
June 19, 2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
James F Howard, Vera Bril, Tuan Vu, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 24, 2018
Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Aleksandra Kacar, Bogdan Bjelica, Ivo Bozovic, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
|
December 3, 2019
Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia
Stojan Peric, Jelena Stevanovic, Katherine Johnson, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 14, 2015
Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans
Stojan Peric, Vuk Milosevic, Ivana Berisavac, et al.
Frontiers in Neurology
|
February 6, 2024
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
James F Howard, Vera Bril, Tuan Vu, et al.
JAMA Neurology
|
April 27, 2026
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial
Francesco Saccà, Gino Gialdini, James F Howard, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
European Journal of Neurology
|
November 17, 2025
Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe
Veronica Sian, Maria Francesca Di Feo, Sergei Kurbatov, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
April 27, 2020
Disability and quality of life in Guillain-Barré syndrome - Longitudinal study
Ivana Berisavac, Mirjana Arsenijevic, Ivo Bozovic, et al.
Journal of Neurology
|
November 1, 2017
Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Ivo Bozovic, Aleksandra Kacar, Stojan Peric, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 2, 2020
Incidence and mortality rates of Guillain-Barré syndrome in Serbia
Aleksandar Stojanov, Ivana Berisavac, Ivo Bozovic, et al.
The Lancet. Neurology
|
June 19, 2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
James F Howard, Vera Bril, Tuan Vu, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 24, 2018
Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Aleksandra Kacar, Bogdan Bjelica, Ivo Bozovic, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
|
December 3, 2019
Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia
Stojan Peric, Jelena Stevanovic, Katherine Johnson, et al.
Journal of the Peripheral Nervous System : JPNS
|
January 14, 2015
Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans
Stojan Peric, Vuk Milosevic, Ivana Berisavac, et al.
Frontiers in Neurology
|
February 6, 2024
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
James F Howard, Vera Bril, Tuan Vu, et al.
JAMA Neurology
|
April 27, 2026
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial
Francesco Saccà, Gino Gialdini, James F Howard, et al.
Page
of 12